2 ms·
From the abstract of the source report [1] >From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), no
by epistasis 9y ago
From the abstract of the source report [1]
>From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non-Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% per year) women but were stable in non-Hispanic white (NHW) and American Indian/Alaska Native (AI/AN) women. The increasing trends were driven by increases in hormone receptor-positive breast cancer, which increased among all racial/ethnic groups, whereas rates of hormone receptor-negative breast cancers decreased.
See also Figure 5, and the paragraph above it with the subheading of "Incidence" in the "Temporal Trends" section:
>Much of the historic increase in breast cancer incidence rates reflect changes in reproductive patterns, such as delayed childbearing and having fewer children, which are recognized risk factors for breast cancer.[22, 23] Incidence rates of in situ and invasive breast cancer rose rapidly during the 1980s and 1990s (Fig. 5), largely because of increased use of mammography screening in the United States. The widespread uptake of mammography screening inflated the incidence rate, because cancers were being diagnosed 1 to 3 years earlier than they would have been in the absence of screening, and screening also may have led to the detection of indolent cases. Invasive breast cancer rates stabilized between 1987 and 1994, followed by a slower increase during the late 1990s. The continued increase particularly among older women may reflect rising rates of obesity and the use of menopausal hormones, both of which increase the risk of postmenopausal breast cancer, as well as further increases in the prevalence of mammography screening.[24] Around the year 2000, incidence rates began to decline among women ages 50 years and older; and, between 2002 and 2003, breast cancer rates decreased nearly 7%, likely because of the decreased use of menopausal hormones after publication of the Women's Health Initiative randomized trial results linking the use of estrogen plus progesterone menopausal hormone therapy to breast cancer and heart disease.[25-27] The decline occurred primarily in white women and in those who had HR-positive disease.[26, 28] The drop in incidence may also reflect in part the small declines in mammography screening since 2000. The percentage of women aged 40 years and older who reported having a mammogram within the past 2 years increased from 29% in 1987 to 70% in 2000 and dropped to 64% in 2015.[29]
[1] http://onlinelibrary.wiley.com/doi/10.3322/caac.21412/full http://onlinelibrary.wiley.com/doi/10.3322/caac.21412/full